African trypanosomiasis
After its introduction to the market in the 1980s, eflornithine has replaced melarsoprol as the first line medication against Human African trypanosomiasis (HAT) due to its reduced toxicity to the host. "Trypanosoma brucei" resistant to eflornithine was reported as early as the mid-1980s.